Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Edoxaban, Oral Anticoagulant

Drug (brand / generic)

Lixiana / edoxaban

Company/Licensee

Daiichi Sankyo

Therapy Class

Anticoagulant

Product Description

Oral factor Xa inhibitor

Current Indication

Thromboembolism

Market Sector

Haematology

Development Status

Approved in Japan; Phase III ongoing globally
Expand

Go Top